Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Erdogan Isikman"'
Autor:
Sevgi Gözdaşoğlu, Ali Pamir, Emel Ünal, İsmail Haluk Gökçora, Ömer Uluoğlu, Koray Ceyhan, Haluk Deda, Erdoğan Işıkman, Gülsan Yavuz, Nurdan Taçyıldız, Ayhan Çavdar
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 1, Pp 66-70 (2016)
Patients who survive Hodgkin lymphoma (HL) are at increased risk of secondary neoplasms (SNs). A wide variety of SNs have been reported, including leukemias, non-Hodgkin's lymphomas, and solid tumors, specifically breast and thyroid cancers. Herein w
Externí odkaz:
https://doaj.org/article/e10b6c4198674f26921046703f80101e
Autor:
Ali Pamir, Koray Ceyhan, Haluk Deda, İsmail Haluk Gökçora, Erdogan Isikman, Emel Ünal, Ayhan O. Çavdar, Sevgi Gözdaşoğlu, Gulsan Yavuz, Uluoğlu O, Nurdan Tacyildiz
Publikováno v:
Turkish Journal of Hematology
Turkish Journal of Hematology, Vol 33, Iss 1, Pp 66-70 (2016)
Turkish Journal of Hematology, Vol 33, Iss 1, Pp 66-70 (2016)
Patients who survive Hodgkin lymphoma (HL) are at increased risk of secondary neoplasms (SNs). A wide variety of SNs have been reported, including leukemias, non-Hodgkin's lymphomas, and solid tumors, specifically breast and thyroid cancers. Herein w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9589eb16fa9b499faa40143e3e82b32a
http://europepmc.org/articles/PMC4805347
http://europepmc.org/articles/PMC4805347
Publikováno v:
Journal of surgical oncology. 33(1)
Metastases from basal cell carcinoma (BCC) are very rare. Some clinical and histologic features have been demonstrated in these cases without corroborative evidence. Treatment of these cases has been disappointing. In this article, we report a patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b24bb3f7d17cde4340988062d3f22e6
https://pubmed.ncbi.nlm.nih.gov/3762176
https://pubmed.ncbi.nlm.nih.gov/3762176